Skip to content

Clinical trials

Phase 2 Idiopathic Pulmonary Fibrosis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Phase: Phase 2 Country / region: United Kingdom Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20133
20142
20151
20162
20172
20182
20193
20203
20223
20233
20247
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated10
Recruiting8
Active, not recruiting5
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Avalyn Pharma Inc.2
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Trevi Therapeutics2
Vicore Pharma AB2
AbbVie1
Amgen1
AstraZeneca1
Biogen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis42
Pulmonary Fibrosis8
Lung Diseases, Interstitial6
Fibrosis4
Cough3
Idiopathic Interstitial Pneumonias2
Hypoxia1
Lung Diseases1
Pathologic Processes1
Respiration Disorders1

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.